动脉血气试剂盒市场增长、规模、份额、趋势、关键参与者分析及 2031 年预测

  • Report Code : TIPRE00012482
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 437
Buy Now

Arterial Blood Gas Kits Market Analysis and Size by 2031

Buy Now

动脉血气试剂盒市场规模预计将从 2023 年的 7.1246 亿美元增至 2031 年的 12.9803 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 7.8%。安全自动化试剂盒的开发以及电子病历的整合可能仍是市场的主要趋势。

动脉血气分析试剂盒市场分析

肾脏疾病和代谢疾病的患病率不断上升、动脉血气试剂盒的技术进步以及发达国家对个性化医疗的日益重视都是动脉血气试剂盒市场发展的有利因素。新兴国家对即时诊断的采用率不断上升,预计也将在未来几年使市场受益。

动脉血气试剂盒市场概述

预计 2023 年至 2031 年,印度将成为全球动脉血气试剂盒市场最高的复合年增长率。在印度,呼吸系统疾病是造成人民生活质量低下的原因。对哮喘、慢性阻塞性肺病和呼吸综合征等呼吸系统疾病的认识的提高将为该国市场提供利润丰厚的增长机会。呼吸窘迫综合征 (RDS) 是印度早产儿中常见的呼吸系统疾病,每年导致 15 万人死亡。根据全球疾病负担 (GBD) 的一份报告,慢性阻塞性肺疾病 (COPD) 是印度死亡和伤残调整生命年 (DALY) 的第二大原因。根据 2020 年 4 月发布的《柳叶刀全球健康》数据,哮喘是全球约 3 亿人的致病原因,其中 3790 万是印度人。印度政府的统计数据表明,印度作为世界第二人口大国,在过去 50 年里经历了巨大的人口变化,60 岁以上的老年人口几乎增加了两倍。 据 BQ Prime 文章报道到2021年,印度60岁及以上人口约为1.38亿,预计到2031年底这一数字将达到1.94亿。预计到2050年,印度老年人口将超过14岁以下儿童人口。是急性呼吸道疾病的独立预测因子,特别是对于病情危重的老年人。例如,MGR 博士教育和研究所大学正在进行一项名为“ACS 医学院三级护理中心急性心力衰竭患者动脉血气 (ABG) 概况分析”的研究,其中他们研究了动脉血气导致心力衰竭患者被送往三级护理中心。因此,由于老年人口的不断增长和呼吸护理领域持续的研究活动,印度的动脉血气试剂盒市场可能在未来几年蓬勃发展。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

动脉血气分析试剂盒市场:

Arterial Blood Gas Kits Market: Strategic Insights

Arterial Blood Gas Kits Market
  • CAGR
    CAGR (2023 - 2031)
    7.8%
  • Market Size 2023
    US$ 712.46 Million
  • Market Size 2031
    US$ 1,298.03 Million

Market Dynamics

GROWTH DRIVERS
  • 需要测量血气水平的呼吸系统疾病发病率不断增加
FUTURE TRENDS
  • 医院急诊科的入院人数不断增加,需要持续监测血液统计数据
OPPORTUNITIES
  • 新兴国家即时诊断的采用率激增

Key Players

  • BD
  • Radiometer Medical ApS
  • Vyaire Medical Inc
  • Opti Medical Systems
  • Siemens Healthineers AG
  • AdvaCare Pharma USA LLC
  • Becton Dickinson and Co
  • ICU Medical Inc
  • SunMed Group Holdings LLC AirLife
  • Trudell Healthcare Solutions Inc

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1注射器类型(鲁尔滑动注射器、鲁尔锁注射器)
    Segment2类型(通风、非通风)
      Segment3使用方法(预设柱塞模式、手动抽吸)
        Segment4应用(体外诊断(pH 血气、氧含量)、电解质分析)

          动脉血气试剂盒市场
          • Arterial Blood Gas Kits Market
            年均复合增长率(2023 - 2031)
            7.8%
          • 2023年市场规模
            71246万美元
          • 2031 年市场规模
            12.9803 亿美元

          市场动态

          增长动力
          • 需要测量血气水平的呼吸系统疾病发病率不断增加
          未来的趋势
          • 医院急诊科的入院人数不断增加,需要持续监测血液统计数据
          机会
          • 新兴国家即时诊断的采用率激增

          关键人物;主力;重要一员

          • BD
          • 辐射计医疗应用软件
          • Vyaire 医疗公司
          • 奥普蒂医疗系统
          • 西门子医疗股份公司
          • AdvaCare Pharma 美国有限责任公司
          • 贝克顿迪金森公司
          • ICU医疗公司
          • SunMed Group Holdings LLC(AirLife)
          • 特鲁德尔医疗解决方案公司

          区域概况

          Arterial Blood Gas Kits Market
          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          Arterial Blood Gas Kits Market注射器类型
          • 鲁尔滑注射器
          • 鲁尔锁注射器
          Arterial Blood Gas Kits Market类型
          • 通风
          • 非通风
          Arterial Blood Gas Kits Market用法
          • 预设柱塞模式
          • 手动抽吸
          Arterial Blood Gas Kits Market应用
          • 体外诊断
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          动脉血气试剂盒市场驱动因素和机遇

          呼吸系统疾病发病率上升利好市场

          哮喘、慢性阻塞性肺病(COPD)和肺炎等呼吸系统疾病给世界各国的公共医疗系统带来巨大负担。感染、吸烟和遗传因素可导致严重的呼吸道并发症。 2021 年,美国肺脏协会将慢性阻塞性肺病列为美国第三大死因,当年有超过 1640 万人被诊断出患有这种疾病。美国国家医学图书馆 2022 年发表的文章《德国慢性阻塞性肺疾病家庭远程监测计划的有效性》估计,德国报告了约 600 万慢性阻塞性肺病病例。 2021 年发表的题为《脆弱的瑞士人口对慢性阻塞性肺疾病了解多少?》的文章估计,瑞士约有 40 万人患有慢性阻塞性肺病。根据美国哮喘和过敏基金会的数据,2022 年美国约有 2600 万人患有哮喘。联合国国际儿童紧急基金会 (UNICEF) 表示,每 10 万名儿童中就有近 1,400 人(即每 71 名儿童中就有 1 例)患有哮喘。每年都会被诊断出肺炎。呼吸问题和氧气短缺在患有呼吸系统疾病的患者中很常见。动脉血气 (ABG) 测试用于测量血液中溶解的氧气和二氧化碳气体。该测试是为患有急性和慢性呼吸道疾病的患者提供护理的基础。因此,急慢性呼吸道疾病发病率的激增推动了对动脉血气检测试剂盒的需求。

          新兴国家大量采用即时诊断以创造市场机会

          无法快速诊断是新兴国家各种疾病导致死亡的重要原因。有效的诊断基础设施需要稳定的电力、精密的仪器、昂贵的试剂和训练有素的专业人员;因此,发展中国家的诊断往往因缺乏这些资源而受到限制。此外,现有的诊断能力导致检测时间较长,不适合资源有限的环境。即时诊断可在患者所在地或附近提供即时诊断结果,从而实现快速的临床决策、简化的工作流程和改善患者的治疗效果。对及时干预、高效诊断流程和个性化医疗服务的需求推动了对分散式检测解决方案的需求。即时动脉血气检测试剂盒允许医疗保健提供者在患者床边、急诊室或远程环境中进行关键诊断测试,从而便于现场评估血气参数、电解质水平和酸碱状态。即时诊断分析仪的可访问性和即时性使临床医生能够迅速启动适当的治疗,实时监测患者的反应,并在急性护理情况下优化临床决策。随着制造商专注于开发紧凑、自动化和易于使用的设备,以提供准确和快速的结果,向即时诊断的转变也推动了动脉血气试剂盒的技术进步。即时诊断分析仪与医疗保健工作流程的无缝集成提高了运营效率,缩短了周转时间,并提高了整体患者护理质量。因此,随着医疗保健机构接受即时诊断的优势,发展中国家对便携式和用户友好的动脉血气试剂盒的需求正在上升,这可能会在未来几年为市场创造增长机会。

          动脉血气试剂盒市场报告细分分析

          有助于得出动脉血气试剂盒市场分析的关键部分是注射器类型、用途、类型、针头规格、注射器容量、应用和最终用户。

          • 根据注射器类型,动脉血气试剂盒市场细分为成人鲁尔滑套注射器和鲁尔锁注射器。鲁尔锁注射器部分在 2023 年占据了较大的市场份额。
          • 根据类型,市场分为通风型和非通风型。2023 年,通风型市场占有较大的市场份额。
          • 根据使用情况,市场分为预设柱塞模式和手动抽吸模式。到 2023 年,预设柱塞模式细分市场将占据更大的市场份额。
          • 根据应用,市场分为体外诊断和电解质分析。体外诊断部分进一步细分为 pH 血气、氧含量等。体外诊断部分在 2023 年占据了更大的市场份额。
          • 根据针规,动脉血气试剂盒市场分为23G、23G至25G和大于25G。 2023 年,23G 至 25G 细分市场占据最大市场份额。
          • 根据注射器容量,动脉血气试剂盒市场分为 1 毫升、3 毫升和其他。3 毫升部分在 2023 年占据了最大的市场份额。
          • 根据最终用户,市场分为医院和诊所、诊断实验室等。医院和诊所细分市场在 2023 年占据主导地位。

          动脉血气试剂盒市场份额按地区分析

          动脉血气试剂盒市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。北美在2023年占据主导地位。我们以美国、加拿大和墨西哥为基础对北美动脉血气试剂盒市场进行了分析。慢性心脏和呼吸系统疾病的患病率和发病率不断增加,导致北美国家动脉血气检测试剂盒的使用增加。 2023年,美国将占据北美动脉血气分析仪市场的最大份额。需要进行动脉血气分析的慢性疾病的患病率不断上升,包括呼吸衰竭、急性呼吸窘迫综合征(ARDS)、哮喘、糖尿病酮症酸中毒、肾小管疾病酸中毒、心力衰竭(HF)和先天性代谢疾病是美国在动脉血气分析仪市场中占据最大份额的主要因素。此外,研究机构探索创新治疗应用的合作举措数量不断增加,预计将加速对动脉血气试剂盒的需求。 Radiometer、BD 和西门子 Healthineers AG 是北美地区主要的动脉血气试剂盒制造商。

          动脉血气试剂盒市场报告范围

          报告属性细节
          2023 年的市场规模7.1246亿美元
          2031 年市场规模12.9803亿美元
          全球复合年增长率(2023 - 2031)7.8%
          历史数据2021-2022
          预测期2024-2031
          涵盖的细分市场按注射器类型
          • 鲁尔滑注射器
          • 鲁尔锁注射器
          按类型
          • 通风
          • 非通风
          按用途
          • 预设柱塞模式
          • 手动抽吸
          按申请
          • 体外诊断
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          • BD
          • 辐射计医疗应用软件
          • Vyaire 医疗公司
          • 奥普蒂医疗系统
          • 西门子医疗股份公司
          • AdvaCare Pharma 美国有限责任公司
          • 贝克顿迪金森公司
          • ICU医疗公司
          • SunMed Group Holdings LLC(AirLife)
          • 特鲁德尔医疗解决方案公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          动脉血气试剂盒市场新闻和最新发展

          动脉血气试剂盒市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了动脉血气试剂盒市场的一些发展:

          • AirLife(原 SunMed)宣布在亚利桑那州格伦代尔开设最新的配送中心。这一里程碑标志着 AirLife 致力于通过提高运输效率和订单履行来提供卓越的客户服务。新配送中心占地 326,018 平方英尺,包括 2,520 平方英尺的前台办公空间、323,498 平方英尺的空调操作空间、59 个装运/收货码头以及 1,065 平方英尺的冷库。该设施的物料搬运设备使用先进的锂离子电池运行,以提高能源效率。 [资料来源:AirLife (SunMed Medical),公司网站,2024 年 2 月]

          动脉血气试剂盒市场报告覆盖范围和交付成果

          “动脉血气试剂盒市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:

          • 动脉血气试剂盒市场规模及全球、区域和国家层面所有主要细分市场的预测
          • 动脉血气试剂盒市场趋势以及市场动态,例如驱动因素、限制因素和关键机会
          • 详细的 PEST/波特五力分析和 SWOT 分析
          • 动脉血气试剂盒市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
          • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及动脉血气试剂盒市场的最新发展
          • 详细的公司简介

          Arterial Blood Gas Kits Market Report Scope

          Report Attribute Details
          Market size in US$ 712.46 Million
          Market Size by US$ 1,298.03 Million
          Global CAGR 7.8%
          Historical Data 2021-2022
          Forecast period 2024-2031
          Segments Covered By 注射器类型(鲁尔滑动注射器、鲁尔锁注射器)
          By 类型(通风、非通风)
          By 使用方法(预设柱塞模式、手动抽吸)
          By 应用(体外诊断(pH 血气、氧含量)、电解质分析)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • BD
        • Radiometer Medical ApS
        • Vyaire Medical Inc
        • Opti Medical Systems
        • Siemens Healthineers AG
        • AdvaCare Pharma USA LLC
        • Becton Dickinson and Co
        • ICU Medical Inc
        • SunMed Group Holdings LLC AirLife
        • Trudell Healthcare Solutions Inc
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          What is the expected CAGR of the arterial blood gas kits market?

          The arterial blood gas kits market is anticipated to record a CAGR of 7.8% during 2023–2031.

          Which are the leading players operating in the arterial blood gas kits market?

          BD, Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC ( AirLife), Trudell Healthcare Solutions Inc, Siemens Healthineers, SARSTEDT AG & Co KG, Lepu Medical Technology Beijing Co Ltd, and Levram Lifesciences Pvt. Ltd. are among the key players operating in the market.

          What are the driving factors impacting the arterial blood gas kits market?

          The increasing incidence of respiratory diseases and rising number of admissions to emergency units in hospitals are among the most influential factors bolstering the market growth.

          What are the significant future trends in the arterial blood gas kits market?

          The development of safe & automated kits and integration of electronic medical records are likely to remain key trends in the arterial blood gas kits market.

          What would be the estimated value of the arterial blood gas kits market by 2031?

          The arterial blood gas kits market value is estimated to reach US$ 1,298.03 million in 2031.

          What are the driving factors for the arterial blood gas kits market?

          The development of safe & automated kits and integration of electronic medical records are likely to remain key trends in the arterial blood gas kits market.

          • Radiometer Medical ApS
          • Vyaire Medical Inc
          • Opti Medical Systems
          • Siemens Healthineers AG
          • AdvaCare Pharma USA LLC
          • Becton Dickinson and Co
          • ICU Medical Inc
          • SunMed Group Holdings LLC (AirLife)
          • Trudell Healthcare Solutions Inc
          • SARSTEDT AG & Co KG
          • Lepu Medical Technology Beijing Co Ltd
          • Levram Lifesciences Pvt. Ltd.

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Medical Device : READ MORE..